Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 8-9, 2011, Pages 554-559

  Arababadi, M K ^a   Pourfathollah, A A ^b   Jafarzadeh, A ^a   Hassanshahi, G ^a   Salehi, M ^c   Ahmadabadi, B N ^a   Kennedy, D ^d  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; GLYCINE; HEPATITIS B SURFACE ANTIGEN; THREONINE; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PLASMA; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS TYPING;

GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MUTATION;

EID: 80052522828     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.04.004     Document Type: Article

References (31)

1. Alavian S.M., Fallahian F., Lankarani K.B. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 2007, 16(4):403-406.
2. Azadmanesh K., Mohraz M., Aghakhani A., Edalat R., Jam S., Eslamifar A., et al. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology 2008, 51(4):270-274.
3. Arababadi M.K., Hassanshahi G., Yousefi H. HBV-DNA in hemodialysis patients infected by HCV. Saudi J Kidney Dis Transpl 2009, 20(3):398-401.
4. Arababadi M.K., Hassanshahi G., Yousefi H., Zarandi E.R., Moradi M., Mahmoodi M. No detected hepatitis B virus-DNA in thalassemic patients infected by hepatitis C virus in Kerman province of Iran. Pak J Biol Sci 2008, 11(13):1738-1741.
5. Arababadi M.K., Pourfathollah A.A., Jafarzadeh A., Hassanshahi G., Rezvani M.E. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients. J Gastroenterol Hepatol 2009, 25(1):90-93.
6. Candotti D., Allain J.P. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009, 51(4):798-809.
7. Jafarzadeh A., Arababadi M.K., Mirzaee M., Pourazar A. Occult hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Acta Med Iran 2008, 46:27-32.
8. Pourazar A., Salehi M., Jafarzadeh A., Arababadi M.K., Oreizi F., Shariatinezhad K. Detection of HBV-DNA in HBsAg negative normal blood donors. Iran J Immunol 2005, 2(3):172-176.
9. Fang Y., Teng X., Xu W.Z., Li D., Zhao H.W., Fu L.J., et al. Molecular characterisation and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J Med Virol 2009, 81(5):826-835.
10. Zaaijer H.L., Torres P., Ontanon A., Ponte L.G., Koppelman M.H., Lelie P.N., et al. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection. J Med Virol 2008, 80(8):1344-1349.
11. Awerkiew S., Daumer M., Reiser M., Wend U.C., Pfister H., Kaiser R., et al. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol 2007, 38(1):83-86.
12. Raimondo G., Pollicino T., Cacciola I., Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007, 46(1):160-170.
13. Banerjee A., Chandra P.K., Datta S., Biswas A., Bhattacharya P., Chakraborty S., et al. Frequency and significance of hepatitis B virus surface gene variant circulating among " anti-HBc only" individuals in Eastern India. J Clin Virol 2007, 40(4):312-317.
14. Bremer C.M., Saniewski M., Wend U.C., Torres P., Lelie N., Gerlich W.H., et al. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009, 24:24.
15. Kumar G.T., Kazim S.N., Kumar M., Hissar S., Chauhan R., Basir S.F., et al. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol 2009, 24(4):588-598.
16. Pinarbasi B., Onel D., Cosan F., Akyuz F., Dirlik N., Cakaloglu Y., et al. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. Liver Int 2009, 29(2):227-230.
17. Fang Z.L., Zhuang H., Wang X.Y., Ge X.M., Harrison T.J. Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol 2004, 10(22):3264-3268.
18. Datta S., Banerjee A., Chandra P.K., Chowdhury A., Chakravarty R. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol 2006, 78(1):53-59.
19. Carreno V., Bartolome J., Castillo I., Quiroga J.A. Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol 2008, 18(3):139-157.
20. Shih C.M., Lo S.J., Miyamura T., Chen S.Y., Lee Y.H. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993, 67(10):5823-5832.
21. Amini-Bavil-Olyaee S., Hosseini S.Y., Sabahi F., Alavian S.M. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine. Int J Infect Dis 2008, 12(1):83-87.
22. Matsuoka S., Nirei K., Tamura A., Nakamura H., Matsumura H., Oshiro S., et al. Influence of occult hepatitis B virus co-infection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Intervirology 2008, 51(5):352-361.
23. Emara M.H., El-Gammal N.E., Mohamed L.A., Bahgat M.M. Occult hepatitis B infection in Egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy. Virol J 2010, 17(7):324.
24. Levast M., Larrat S., Thelu M.A., Nicod S., Plages A., Cheveau A., et al. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. J Med Virol 2010, 82(5):747-754.
25. Fallahian F., Najafi A. Epidemiology of hepatitis C in the Middle East. Saudi J Kidney Dis Transpl 2010, 22(1):1-9.
26. Conde S.R., Moia Lde J., Barbosa M.S., Amaral Ido S., Miranda E.C., Soares Mdo C., et al. Prevalence of hepatitis B virus genotypes and the occurrence of precore mutation A-1896 and to correlate them with the clinical presentation of chronic hepatitis, in a population group of the Eastern Amazon region. Rev Soc Bras Med Trop 2004, 37(Suppl 2):33-39.
27. Kao J.H. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology 2003, 46(6):400-407.
28. Yuen M.F., Tanaka Y., Mizokami M., Yuen J.C., Wong D.K., Yuan H.J., et al. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis 2004, 25(9):1593-1598.
29. Katsoulidou A., Paraskevis D., Magiorkinis E., Moschidis Z., Haida C., Hatzitheodorou E., et al. Molecular characterisation of occult hepatitis B cases in Greek blood donors. J Med Virol 2009, 81(5):815-825.
30. van Hemert F.J., Zaaijer H.L., Berkhout B., Lukashov V.V. Occult hepatitis B infection: an evolutionary scenario. Virol J 2008, 5(146):146.
31. Candotti D., Grabarczyk P., Ghiazza P., Roig R., Casamitjana N., Iudicone P., et al. Characterisation of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008, 49(4):537-547.